POLYETHYLENE GLYCOL 400

POLYETHYLENE GLYCOL 400 was reported 12914 times

POLYETHYLENE GLYCOL 400 is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTACID THERAPY 80 0.6154
1 SLEEP DISORDER THERAPY 120 0.6061
2 APPENDICOLITH 215 0.5556
3 MEDICALLY INDUCED PRETERM BIRTH 7 0.4375
4 ANALGESIC THERAPY 123 0.3832
5 DRUG THERAPY 115 0.3392
6 ANTICOAGULANT THERAPY 79 0.2782
7 CONGENITAL HIATUS HERNIA 57 0.2500
8 EXPOSURE TO UNSPECIFIED AGENT 46 0.2347
9 VAGINAL FLATULENCE 70 0.2310
10 MALIGNANT MELANOMA STAGE 0 44 0.2105
11 FOREIGN BODY INGESTION 15 0.1339
12 BINOCULAR EYE MOVEMENT DISORDER 34 0.1181
13 BACTEROIDES INFECTION 30 0.1149
14 CEREBRAL HYPOPERFUSION 50 0.1073
15 VICTIM OF CHILD ABUSE 24 0.0956
16 CEREBELLAR STROKE 34 0.0870
17 CHILD ABUSE 20 0.0772
18 NEUTROPENIA NEONATAL 17 0.0759
19 HYPERPHOSPHATAEMIA 159 0.0739
20 PELVIC KIDNEY 8 0.0690
21 EPIDURAL LIPOMATOSIS 23 0.0669
22 BLOOD PHOSPHORUS INCREASED 178 0.0651
23 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 55 0.0593
24 INCORRECT PRODUCT ADMINISTRATION DURATION 1269 0.0585
25 CEREBRAL ARTERY THROMBOSIS 27 0.0525
26 BRAIN SCAN ABNORMAL 27 0.0484
27 FEMALE GENITAL TRACT FISTULA 72 0.0421
28 NASAL HERPES 8 0.0394
29 HYPONATRAEMIC SEIZURE 8 0.0315
30 CHRONIC SINUSITIS 117 0.0311
31 CATARRH 26 0.0288
32 PROCTITIS 78 0.0278
33 TOTAL LUNG CAPACITY DECREASED 44 0.0275
34 RADICULOPATHY 71 0.0269
35 STEROID DEPENDENCE 23 0.0262
36 IRON DEFICIENCY 115 0.0255
37 BLOOD URIC ACID INCREASED 146 0.0253
38 FOETAL DISORDER 21 0.0251
39 APPENDICITIS 221 0.0236
40 GINGIVAL ABSCESS 17 0.0225
41 INCORRECT DRUG ADMINISTRATION DURATION 625 0.0222
42 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 110 0.0217
43 AORTIC STENOSIS 73 0.0209
44 FAECAL VOLUME DECREASED 10 0.0208
45 HYPOPHOSPHATAEMIA 152 0.0205
46 MYASTHENIA GRAVIS 159 0.0197
47 HYPORESPONSIVE TO STIMULI 23 0.0196
48 VENTRICULAR FIBRILLATION 211 0.0190
49 DIABETIC KETOSIS 7 0.0184
50 LUNG OPACITY 46 0.0174
51 BURNS SECOND DEGREE 28 0.0159
52 PLEURITIC PAIN 44 0.0159
53 CARDIOGENIC SHOCK 222 0.0155
54 SCIATIC NERVE INJURY 12 0.0144
55 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 87 0.0143
56 MACULAR DEGENERATION 166 0.0139
57 THERAPEUTIC PRODUCT EFFECT VARIABLE 51 0.0131
58 SLOW RESPONSE TO STIMULI 17 0.0131
59 RESPIRATORY SYMPTOM 36 0.0126
60 TROPONIN INCREASED 91 0.0119
61 THERAPEUTIC PRODUCT EFFECT DELAYED 54 0.0118
62 INTESTINAL PSEUDO-OBSTRUCTION 10 0.0114
63 BREATH SOUNDS ABNORMAL 56 0.0113
64 TONGUE PARALYSIS 8 0.0112
65 ENTEROCOCCUS TEST POSITIVE 7 0.0108
66 BENIGN PROSTATIC HYPERPLASIA 55 0.0106
67 BLOOD PRESSURE DIASTOLIC ABNORMAL 27 0.0106
68 PSEUDOMONAL BACTERAEMIA 9 0.0105
69 AREFLEXIA 28 0.0105
70 FAECES SOFT 76 0.0104
71 BLISTER INFECTED 8 0.0102
72 ALCOHOL POISONING 27 0.0101
73 PRODUCT AFTER TASTE 9 0.0094
74 NEUTROPENIC INFECTION 9 0.0094
75 JUVENILE IDIOPATHIC ARTHRITIS 23 0.0094
76 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 25 0.0094
77 BACTERIAL INFECTION 175 0.0094
78 BLOOD CALCIUM INCREASED 82 0.0093
79 FAECALOMA 50 0.0091
80 ANAL INCONTINENCE 82 0.0091
81 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 155 0.0090
82 MULTIPLE ORGAN DYSFUNCTION SYNDROME 241 0.0085
83 HYPOPNOEA 29 0.0083
84 MICTURITION URGENCY 95 0.0083
85 HYPERLIPIDAEMIA 99 0.0083
86 FREQUENT BOWEL MOVEMENTS 223 0.0082
87 NEURALGIA 200 0.0082
88 UNDERDOSE 598 0.0082
89 ABNORMAL FAECES 67 0.0082
90 ASCITES 240 0.0082
91 MYCOBACTERIAL INFECTION 14 0.0081
92 DRUG EFFECT VARIABLE 9 0.0079
93 BRONCHIECTASIS 53 0.0079
94 BLOOD PRESSURE SYSTOLIC ABNORMAL 19 0.0077
95 PSYCHIATRIC DECOMPENSATION 15 0.0077
96 ON AND OFF PHENOMENON 42 0.0076
97 VAGINAL DISCHARGE 76 0.0075
98 KLEBSIELLA BACTERAEMIA 7 0.0074
99 DRUG EFFECT LESS THAN EXPECTED 109 0.0073
100 PARAESTHESIA ORAL 105 0.0073
101 FAECES HARD 27 0.0069
102 RECTAL PROLAPSE 8 0.0066
103 RESPIRATORY ACIDOSIS 26 0.0066
104 HEPATIC CYTOLYSIS 84 0.0066
105 FRACTURED SACRUM 8 0.0064
106 HYPONATRAEMIA 362 0.0064
107 RENAL MASS 13 0.0063
108 TROPONIN T INCREASED 8 0.0063
109 ORAL CANDIDIASIS 83 0.0063
110 EXPIRED PRODUCT ADMINISTERED 208 0.0063
111 PNEUMONIA VIRAL 19 0.0060
112 ASPIRATION 65 0.0059
113 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 42 0.0059
114 ULCER 93 0.0058
115 GOUT 103 0.0057
116 VASCULAR PURPURA 8 0.0057
117 HYPERCAPNIA 17 0.0056
118 BICYTOPENIA 11 0.0056
119 DYSCHEZIA 17 0.0056
120 END STAGE RENAL DISEASE 101 0.0055
121 BLOOD TEST ABNORMAL 77 0.0055
122 FRUSTRATION TOLERANCE DECREASED 44 0.0054
123 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 9 0.0054
124 APLASTIC ANAEMIA 28 0.0054
125 ABDOMINAL DISTENSION 544 0.0052
126 CARBON DIOXIDE INCREASED 7 0.0051
127 AUTONOMIC NERVOUS SYSTEM IMBALANCE 15 0.0051
128 CARDIAC MURMUR 44 0.0051
129 VASCULAR DEVICE INFECTION 23 0.0051
130 RASH MORBILLIFORM 14 0.0050
131 INTESTINAL ULCER 8 0.0050
132 BEHAVIOUR DISORDER 27 0.0050
133 CLOSTRIDIUM TEST POSITIVE 11 0.0050
134 INTENSIVE CARE 7 0.0049
135 ESSENTIAL HYPERTENSION 9 0.0049
136 FLATULENCE 275 0.0048
137 SWOLLEN TONGUE 151 0.0048
138 FULL BLOOD COUNT ABNORMAL 51 0.0048
139 WRONG PATIENT RECEIVED PRODUCT 14 0.0048
140 HYPERCHOLESTEROLAEMIA 46 0.0048
141 LUNG CONSOLIDATION 13 0.0046
142 ANTIPSYCHOTIC DRUG LEVEL INCREASED 13 0.0046
143 CHOLESTATIC LIVER INJURY 10 0.0045
144 ANAL FISSURE 24 0.0045
145 HEPATIC LESION 19 0.0044
146 MIXED LIVER INJURY 13 0.0043
147 RALES 25 0.0043
148 DYSENTERY 8 0.0043
149 THERAPEUTIC PRODUCT EFFECT DECREASED 190 0.0042
150 JAUNDICE NEONATAL 8 0.0042
151 PANCREATIC CYST 8 0.0042
152 CEREBELLAR SYNDROME 9 0.0041
153 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
154 PYELONEPHRITIS ACUTE 8 0.0041
155 RHINITIS 32 0.0040
156 NOCTURIA 48 0.0040
157 INTRACRANIAL PRESSURE INCREASED 22 0.0039
158 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 206 0.0039
159 IRON DEFICIENCY ANAEMIA 36 0.0039
160 FEBRILE NEUTROPENIA 258 0.0039
161 FACIAL PARALYSIS 33 0.0039
162 CUTANEOUS VASCULITIS 14 0.0038
163 BLOOD CREATININE DECREASED 12 0.0038
164 PROCEDURAL PAIN 106 0.0038
165 GINGIVAL PAIN 30 0.0038
166 PROCTALGIA 24 0.0037
167 PAROSMIA 28 0.0037
168 ISCHAEMIC STROKE 66 0.0037
169 SPUTUM DISCOLOURED 35 0.0037
170 BLOOD CHOLESTEROL INCREASED 168 0.0036
171 RHINOVIRUS INFECTION 14 0.0036
172 APHTHOUS ULCER 27 0.0035
173 BLOOD PRESSURE DIASTOLIC INCREASED 16 0.0035
174 CONSTIPATION 755 0.0035
175 EYELID PAIN 7 0.0034
176 RECTAL HAEMORRHAGE 147 0.0034
177 ESCHERICHIA BACTERAEMIA 8 0.0034
178 FAECES DISCOLOURED 73 0.0034
179 HEMIPLEGIA 28 0.0034
180 SUSPECTED OFF LABEL USE 15 0.0033
181 CYTOKINE RELEASE SYNDROME 65 0.0032
182 ANAL HAEMORRHAGE 9 0.0032
183 ENDOTRACHEAL INTUBATION 9 0.0032
184 MICTURITION DISORDER 11 0.0032
185 TOXIC ENCEPHALOPATHY 16 0.0032
186 MEAN CELL VOLUME INCREASED 8 0.0031
187 SEPSIS 345 0.0031
188 THERAPEUTIC REACTION TIME DECREASED 9 0.0031
189 DRUG INTOLERANCE 296 0.0031
190 GENERAL PHYSICAL HEALTH DETERIORATION 354 0.0031
191 FEBRILE BONE MARROW APLASIA 13 0.0031
192 HAEMATOCHEZIA 168 0.0030
193 DYSPHONIA 178 0.0030
194 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 18 0.0030
195 EOSINOPHILIA 53 0.0030
196 BOWEL MOVEMENT IRREGULARITY 23 0.0030
197 LARGE INTESTINAL ULCER 8 0.0029
198 PRODUCT PRESCRIBING ERROR 70 0.0029
199 SMALL INTESTINAL OBSTRUCTION 36 0.0029
200 TYPE IV HYPERSENSITIVITY REACTION 8 0.0029
201 COLITIS 110 0.0029
202 PRODUCT PREPARATION ISSUE 19 0.0029
203 PULMONARY EMBOLISM 271 0.0028
204 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 156 0.0028
205 FEELING COLD 79 0.0028
206 PERIORBITAL SWELLING 16 0.0028
207 HYPOALBUMINAEMIA 22 0.0028
208 PRODUCT ADMINISTRATION ERROR 57 0.0028
209 HEART VALVE INCOMPETENCE 8 0.0028
210 RESPIRATORY DEPRESSION 34 0.0028
211 LOW BIRTH WEIGHT BABY 22 0.0028
212 STAPHYLOCOCCAL BACTERAEMIA 12 0.0028
213 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 15 0.0028
214 HYPOXIA 97 0.0028
215 DRY MOUTH 223 0.0027
216 PULMONARY PAIN 8 0.0027
217 DYSPHEMIA 12 0.0027
218 DRUG LEVEL BELOW THERAPEUTIC 15 0.0027
219 DEFAECATION URGENCY 19 0.0027
220 CATHETER SITE PAIN 7 0.0027
221 OBSTRUCTIVE AIRWAYS DISORDER 30 0.0027
222 ANGIOEDEMA 119 0.0027
223 ABDOMINAL PAIN 625 0.0027
224 SLEEP DISORDER 189 0.0027
225 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 481 0.0027
226 COLITIS ULCERATIVE 119 0.0027
227 HEPATITIS CHOLESTATIC 16 0.0027
228 IMPAIRED QUALITY OF LIFE 38 0.0026
229 BODY TEMPERATURE DECREASED 26 0.0026
230 GASTROINTESTINAL MOTILITY DISORDER 14 0.0026
231 BLOOD PRESSURE SYSTOLIC INCREASED 51 0.0026
232 PRESYNCOPE 63 0.0026
233 JOINT INJURY 55 0.0026
234 TRANSAMINASES INCREASED 57 0.0026
235 LIVER FUNCTION TEST INCREASED 55 0.0026
236 DEPRESSIVE SYMPTOM 9 0.0026
237 PULMONARY MASS 38 0.0025
238 HYDRONEPHROSIS 19 0.0025
239 RASH MACULO-PAPULAR 56 0.0025
240 DIVERTICULUM INTESTINAL 11 0.0025
241 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 173 0.0024
242 HOSPICE CARE 24 0.0024
243 MUCOUS STOOLS 12 0.0024
244 GASTROINTESTINAL SOUNDS ABNORMAL 12 0.0024
245 HYPERNATRAEMIA 12 0.0024
246 INTENTIONAL PRODUCT MISUSE 210 0.0024
247 DRUG EFFECT DECREASED 128 0.0024
248 DIABETES MELLITUS 179 0.0023
249 BLOOD CULTURE POSITIVE 7 0.0023
250 BLOOD CREATININE INCREASED 151 0.0023
251 ATELECTASIS 22 0.0023
252 HYPOKALAEMIA 105 0.0023
253 DIZZINESS POSTURAL 22 0.0023
254 LEUKOCYTOSIS 41 0.0023
255 CLOSTRIDIUM DIFFICILE COLITIS 24 0.0023
256 INFUSION SITE ERYTHEMA 19 0.0023
257 THROMBOSIS 181 0.0022
258 ANAEMIA 429 0.0022
259 COLITIS ISCHAEMIC 15 0.0022
260 TENDERNESS 23 0.0022
261 LYMPHOCYTE COUNT DECREASED 39 0.0022
262 DRUG EFFECT DELAYED 10 0.0022
263 BLADDER PAIN 7 0.0022
264 TIC 12 0.0022
265 BACTERAEMIA 26 0.0022
266 HYPERURICAEMIA 9 0.0022
267 ENTERITIS 14 0.0022
268 GASTROINTESTINAL PAIN 24 0.0022
269 INFUSION RELATED REACTION 144 0.0022
270 SWELLING FACE 140 0.0021
271 BLOOD ALBUMIN DECREASED 17 0.0021
272 GENERAL SYMPTOM 16 0.0021
273 INFUSION SITE HAEMORRHAGE 7 0.0021
274 SKIN ABRASION 10 0.0021
275 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 7 0.0021
276 SINUS TACHYCARDIA 30 0.0021
277 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
278 GENERALISED OEDEMA 26 0.0021
279 TRANSFUSION 22 0.0021
280 THYROID MASS 8 0.0021
281 PYELONEPHRITIS 18 0.0021
282 SWELLING OF EYELID 13 0.0021
283 HYPOKINESIA 30 0.0021
284 NEUTROPHIL COUNT INCREASED 21 0.0020
285 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
286 ACUTE RESPIRATORY FAILURE 39 0.0020
287 OBESITY 32 0.0020
288 CAROTID ARTERY STENOSIS 7 0.0020
289 ASTHENOPIA 11 0.0020
290 LOWER RESPIRATORY TRACT INFECTION 91 0.0020
291 INTESTINAL OBSTRUCTION 75 0.0020
292 IMPAIRED GASTRIC EMPTYING 27 0.0020
293 VITAMIN B12 DEFICIENCY 8 0.0020
294 SWELLING 184 0.0020
295 EYE PAIN 110 0.0019
296 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 137 0.0019
297 TUBULOINTERSTITIAL NEPHRITIS 36 0.0019
298 CORONARY ARTERY DISEASE 58 0.0019
299 RESPIRATORY RATE INCREASED 17 0.0019
300 PULSELESS ELECTRICAL ACTIVITY 8 0.0019
301 INFUSION SITE SWELLING 12 0.0019
302 HALLUCINATIONS, MIXED 8 0.0019
303 GAMMA-GLUTAMYLTRANSFERASE INCREASED 42 0.0019
304 ANORECTAL DISCOMFORT 10 0.0019
305 MALNUTRITION 21 0.0019
306 FAECAL INCONTINENCE 9 0.0019
307 HAEMOGLOBIN ABNORMAL 12 0.0019
308 HAEMOPTYSIS 52 0.0019
309 ABDOMINAL PAIN LOWER 47 0.0019
310 URINARY RETENTION 62 0.0019
311 NEUROLEPTIC MALIGNANT SYNDROME 22 0.0019
312 INCORRECT DOSE ADMINISTERED 423 0.0019
313 HORDEOLUM 8 0.0018
314 DIPLOPIA 48 0.0018
315 ENCEPHALOPATHY 45 0.0018
316 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 88 0.0018
317 ASPARTATE AMINOTRANSFERASE INCREASED 97 0.0018
318 UPPER RESPIRATORY TRACT INFECTION 84 0.0018
319 DIABETIC NEUROPATHY 9 0.0018
320 CYSTIC FIBROSIS 10 0.0018
321 ILEUS PARALYTIC 8 0.0018
322 RESPIRATORY DISTRESS 49 0.0018
323 HALLUCINATION, VISUAL 37 0.0018
324 IMMUNE THROMBOCYTOPENIA 8 0.0017
325 PLEURAL EFFUSION 106 0.0017
326 HEART RATE DECREASED 61 0.0017
327 FOREIGN BODY SENSATION IN EYES 11 0.0017
328 HYPERTRANSAMINASAEMIA 12 0.0017
329 BLOOD POTASSIUM INCREASED 28 0.0017
330 ABDOMINAL PAIN UPPER 355 0.0017
331 AGRANULOCYTOSIS 32 0.0017
332 TRANSIENT ISCHAEMIC ATTACK 58 0.0017
333 HAEMATOCRIT DECREASED 34 0.0017
334 BLADDER DISORDER 17 0.0017
335 SOMNOLENCE 341 0.0017
336 BRONCHOSPASM 24 0.0017
337 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 13 0.0017
338 CHOLESTASIS 32 0.0017
339 HUMERUS FRACTURE 8 0.0017
340 BURSITIS 20 0.0016
341 SKIN REACTION 23 0.0016
342 ABNORMAL SENSATION IN EYE 7 0.0016
343 DYSARTHRIA 61 0.0016
344 STREPTOCOCCAL INFECTION 9 0.0016
345 ABDOMINAL TENDERNESS 8 0.0016
346 IMMUNODEFICIENCY 24 0.0016
347 INTESTINAL PERFORATION 18 0.0016
348 OCULAR DISCOMFORT 18 0.0016
349 PNEUMONIA ASPIRATION 40 0.0016
350 DYSPEPSIA 157 0.0016
351 PRODUCTIVE COUGH 76 0.0016
352 PRODUCT SOLUBILITY ABNORMAL 8 0.0016
353 CONDITION AGGRAVATED 481 0.0016
354 OSTEOPENIA 24 0.0016
355 ACUTE KIDNEY INJURY 242 0.0016
356 ESCHERICHIA INFECTION 13 0.0016
357 CARDIOVASCULAR DISORDER 40 0.0016
358 DRUG LEVEL DECREASED 16 0.0016
359 HYPOPHAGIA 40 0.0016
360 FOOD ALLERGY 12 0.0016
361 INTENTIONAL PRODUCT USE ISSUE 136 0.0016
362 FAILURE TO THRIVE 8 0.0015
363 HERPES SIMPLEX 10 0.0015
364 HYPOVOLAEMIA 9 0.0015
365 VITAMIN D DEFICIENCY 15 0.0015
366 ABDOMINAL HERNIA 7 0.0015
367 OFF LABEL USE 1342 0.0015
368 THROMBOCYTOPENIA 171 0.0015
369 MUCOSAL INFLAMMATION 40 0.0015
370 LUMBAR VERTEBRAL FRACTURE 7 0.0015
371 SPEECH DISORDER 80 0.0015
372 BRADYKINESIA 9 0.0015
373 UROSEPSIS 14 0.0015
374 PLEURISY 9 0.0015
375 HYPERKALAEMIA 53 0.0015
376 ARTERIOSCLEROSIS 14 0.0015
377 URINE OUTPUT DECREASED 13 0.0015
378 SHOCK HAEMORRHAGIC 12 0.0015
379 CLOSTRIDIUM DIFFICILE INFECTION 32 0.0015
380 PULMONARY FIBROSIS 28 0.0015
381 HYPOTENSION 291 0.0014
382 POOR VENOUS ACCESS 15 0.0014
383 ENTEROCOCCAL INFECTION 7 0.0014
384 DROOLING 10 0.0014
385 LYMPHOEDEMA 10 0.0014
386 HAEMORRHOIDAL HAEMORRHAGE 7 0.0014
387 BLOOD POTASSIUM DECREASED 43 0.0014
388 CONFUSIONAL STATE 229 0.0014
389 DELUSION 22 0.0014
390 DIARRHOEA 913 0.0014
391 EYE IRRITATION 81 0.0014
392 VOMITING 661 0.0014
393 BRAIN FOG 22 0.0014
394 DYSGEUSIA 104 0.0014
395 DRUG INEFFECTIVE 1836 0.0014
396 CONTRAINDICATED PRODUCT ADMINISTERED 42 0.0014
397 FLANK PAIN 13 0.0014
398 HYPOTHERMIA 14 0.0014
399 PANCREATITIS ACUTE 31 0.0014
400 MOUTH ULCERATION 29 0.0014
401 GASTROENTERITIS 20 0.0014
402 PYREXIA 473 0.0014
403 TUMOUR LYSIS SYNDROME 12 0.0014
404 IMPAIRED WORK ABILITY 29 0.0014
405 HEAD DISCOMFORT 24 0.0014
406 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
407 LUNG DISORDER 66 0.0013
408 MUSCLE RIGIDITY 16 0.0013
409 POLYNEUROPATHY 16 0.0013
410 BLOOD CALCIUM DECREASED 15 0.0013
411 POSTOPERATIVE WOUND INFECTION 9 0.0013
412 DRUG LEVEL INCREASED 22 0.0013
413 OEDEMA PERIPHERAL 162 0.0013
414 BLOOD LACTIC ACID INCREASED 7 0.0013
415 RENAL TUBULAR NECROSIS 13 0.0013
416 NEUTROPHIL COUNT DECREASED 54 0.0013
417 HYPOCALCAEMIA 25 0.0013
418 ORTHOSTATIC HYPOTENSION 23 0.0013
419 CYSTITIS 42 0.0013
420 HYPERTHERMIA 10 0.0013
421 MYOCARDITIS 15 0.0013
422 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
423 PNEUMONIA BACTERIAL 12 0.0013
424 COMPRESSION FRACTURE 7 0.0013
425 PANCYTOPENIA 73 0.0013
426 NIGHTMARE 45 0.0013
427 LARGE INTESTINE POLYP 9 0.0013
428 LARGE INTESTINE PERFORATION 9 0.0013
429 HYPERCALCAEMIA 16 0.0013
430 BLOOD PRESSURE FLUCTUATION 31 0.0013
431 WEIGHT DECREASED 360 0.0013
432 ILEUS 16 0.0013
433 OESOPHAGITIS 14 0.0013
434 APPLICATION SITE REACTION 9 0.0013
435 DYSURIA 47 0.0013
436 GASTROINTESTINAL INFLAMMATION 10 0.0013
437 ABDOMINAL DISCOMFORT 213 0.0013
438 MUSCULOSKELETAL STIFFNESS 111 0.0013
439 BRAIN OEDEMA 16 0.0013
440 RETCHING 27 0.0013
441 HAEMATOTOXICITY 12 0.0013
442 BLOOD BILIRUBIN INCREASED 34 0.0013
443 EYE INFLAMMATION 12 0.0013
444 SCREAMING 8 0.0013
445 PRODUCT TASTE ABNORMAL 17 0.0013
446 TOXIC EPIDERMAL NECROLYSIS 19 0.0012
447 SKIN INFECTION 14 0.0012
448 DEEP VEIN THROMBOSIS 81 0.0012
449 NAUSEA 986 0.0012
450 C-REACTIVE PROTEIN INCREASED 45 0.0012
451 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 21 0.0012
452 INCOHERENT 8 0.0012
453 HIATUS HERNIA 16 0.0012
454 NEUTROPENIA 168 0.0012
455 CHOKING 24 0.0012
456 ORAL DISCOMFORT 17 0.0012
457 HYPERTONIA 7 0.0012
458 HEPATOMEGALY 12 0.0012
459 GENERALISED TONIC-CLONIC SEIZURE 20 0.0012
460 RESPIRATORY FAILURE 88 0.0012
461 ACCIDENTAL OVERDOSE 44 0.0012
462 HYPERTRIGLYCERIDAEMIA 7 0.0012
463 TOXIC SKIN ERUPTION 12 0.0012
464 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
465 ATAXIA 14 0.0012
466 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12 0.0012
467 PSEUDOMONAS INFECTION 10 0.0012
468 PRODUCT USE IN UNAPPROVED INDICATION 288 0.0012
469 RESPIRATION ABNORMAL 8 0.0012
470 DEHYDRATION 154 0.0012
471 OVERDOSE 249 0.0012
472 PLATELET COUNT INCREASED 15 0.0011
473 HYPOMAGNESAEMIA 16 0.0011
474 MITRAL VALVE INCOMPETENCE 13 0.0011
475 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
476 WEIGHT FLUCTUATION 12 0.0011
477 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
478 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
479 PULMONARY CONGESTION 15 0.0011
480 HYPERSENSITIVITY 210 0.0011
481 WHEEZING 67 0.0011
482 PARKINSONISM 11 0.0011
483 CARDIO-RESPIRATORY ARREST 47 0.0011
484 ANAPHYLACTIC REACTION 62 0.0011
485 ECONOMIC PROBLEM 17 0.0011
486 ELECTROLYTE IMBALANCE 13 0.0011
487 BLOOD SODIUM DECREASED 21 0.0011
488 LACTIC ACIDOSIS 36 0.0011
489 MUSCLE DISORDER 9 0.0011
490 ALTERED STATE OF CONSCIOUSNESS 24 0.0011
491 COVID-19 PNEUMONIA 13 0.0011
492 LIP DRY 10 0.0011
493 POLYURIA 9 0.0011
494 ASTHENIA 412 0.0011
495 BLOOD IRON DECREASED 13 0.0011
496 NEUROPATHY PERIPHERAL 104 0.0011
497 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
498 TACHYCARDIA 97 0.0011
499 ORAL DISORDER 8 0.0011
500 SEIZURE 126 0.0011
501 DENTAL CARIES 12 0.0011
502 NEUROTOXICITY 19 0.0011
503 LIVER DISORDER 48 0.0011
504 PRODUCT USE COMPLAINT 17 0.0011
505 ORAL HERPES 21 0.0011
506 COVID-19 188 0.0011
507 POOR QUALITY SLEEP 23 0.0011
508 OXYGEN SATURATION DECREASED 60 0.0011
509 TREMOR 177 0.0011
510 DELIRIUM 37 0.0011
511 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 8 0.0011
512 PNEUMONITIS 29 0.0011
513 BALANCE DISORDER 92 0.0011
514 DRY EYE 53 0.0011
515 HAEMOGLOBIN DECREASED 109 0.0011
516 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
517 APPETITE DISORDER 7 0.0011
518 POISONING DELIBERATE 10 0.0011
519 PETECHIAE 11 0.0011
520 URINARY INCONTINENCE 31 0.0010
521 UNRESPONSIVE TO STIMULI 27 0.0010
522 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
523 PNEUMONIA 338 0.0010
524 BLOOD MAGNESIUM DECREASED 9 0.0010
525 INCONTINENCE 11 0.0010
526 RENAL PAIN 11 0.0010
527 HAEMOLYSIS 8 0.0010
528 CONCUSSION 8 0.0010
529 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
530 URINARY TRACT INFECTION 176 0.0010
531 POLLAKIURIA 43 0.0010
532 CARDIAC ARREST 85 0.0010
533 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 7 0.0010
534 PELVIC FRACTURE 8 0.0010
535 GASTROINTESTINAL DISORDER 92 0.0010
536 BLOOD PRESSURE INCREASED 157 0.0010
537 SPINAL OSTEOARTHRITIS 9 0.0010
538 TORSADE DE POINTES 8 0.0010
539 SYSTEMIC LUPUS ERYTHEMATOSUS 36 0.0010
540 DIVERTICULITIS 28 0.0010
541 INFUSION SITE PAIN 13 0.0010
542 MENTAL STATUS CHANGES 28 0.0010
543 RHABDOMYOLYSIS 42 0.0010
544 COORDINATION ABNORMAL 14 0.0010
545 HYPOTONIA 10 0.0010
546 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
547 SLEEP APNOEA SYNDROME 19 0.0010
548 HIP FRACTURE 32 0.0010
549 LACRIMATION INCREASED 30 0.0010
550 EATING DISORDER 21 0.0010
551 DECUBITUS ULCER 8 0.0010
552 TINNITUS 45 0.0010
553 SUBDURAL HAEMATOMA 14 0.0010
554 HICCUPS 8 0.0010
555 ASTHMA 110 0.0010
556 RIB FRACTURE 20 0.0010
557 HALLUCINATION 73 0.0010
558 VERTIGO 59 0.0010
559 MYOCARDIAL ISCHAEMIA 11 0.0010
560 EXTRAPYRAMIDAL DISORDER 24 0.0010
561 THINKING ABNORMAL 18 0.0010
562 ATRIAL FIBRILLATION 94 0.0010
563 CYTOMEGALOVIRUS INFECTION 16 0.0010
564 RHINORRHOEA 62 0.0010
565 AGGRESSION 48 0.0010
566 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 194 0.0010
567 PHOTOPHOBIA 18 0.0010
568 TACHYPNOEA 13 0.0010
569 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 28 0.0010
570 PRODUCT ODOUR ABNORMAL 10 0.0010
571 GASTRITIS 25 0.0009
572 SEPTIC SHOCK 41 0.0009
573 SCIATICA 15 0.0009
574 HAEMORRHAGE INTRACRANIAL 14 0.0009
575 HEADACHE 585 0.0009
576 ERUCTATION 18 0.0009
577 COMA 44 0.0009
578 PHARYNGEAL SWELLING 9 0.0009
579 ACIDOSIS 7 0.0009
580 DEPRESSED LEVEL OF CONSCIOUSNESS 36 0.0009
581 GAIT DISTURBANCE 174 0.0009
582 METABOLIC ACIDOSIS 29 0.0009
583 PRODUCT COMMUNICATION ISSUE 8 0.0009
584 ATRIOVENTRICULAR BLOCK 7 0.0009
585 PURPURA 8 0.0009
586 HYPERTENSION 191 0.0009
587 DECREASED APPETITE 209 0.0009
588 HEPATITIS 23 0.0009
589 DYSPHAGIA 85 0.0009
590 FISTULA 10 0.0009
591 STATUS EPILEPTICUS 10 0.0009
592 PREMATURE DELIVERY 14 0.0009
593 HERNIA 17 0.0009
594 SEDATION 23 0.0009
595 ATRIAL FLUTTER 7 0.0009
596 DERMATITIS CONTACT 10 0.0009
597 HYPOTHYROIDISM 28 0.0009
598 EAR PAIN 17 0.0009
599 FALL 291 0.0009
600 BLOOD DISORDER 7 0.0009
601 CELLULITIS 44 0.0009
602 PLASMA CELL MYELOMA 34 0.0009
603 NASAL CONGESTION 51 0.0009
604 EYE DISCHARGE 9 0.0009
605 HYPOGLYCAEMIA 42 0.0009
606 NERVOUS SYSTEM DISORDER 27 0.0009
607 PRODUCT DISTRIBUTION ISSUE 8 0.0009
608 HEPATIC STEATOSIS 16 0.0009
609 ABNORMAL BEHAVIOUR 34 0.0009
610 DISORIENTATION 34 0.0009
611 ARTHRITIS 67 0.0009
612 MENTAL DISORDER 37 0.0008
613 HEART RATE INCREASED 84 0.0008
614 PHOTOSENSITIVITY REACTION 14 0.0008
615 DIABETES MELLITUS INADEQUATE CONTROL 15 0.0008
616 ACUTE CORONARY SYNDROME 7 0.0008
617 NO ADVERSE EVENT 153 0.0008
618 GASTRIC ULCER 16 0.0008
619 FEELING JITTERY 16 0.0008
620 CHOLECYSTITIS 10 0.0008
621 JOINT STIFFNESS 22 0.0008
622 TASTE DISORDER 17 0.0008
623 BLOOD UREA INCREASED 14 0.0008
624 CHILLS 98 0.0008
625 LETHARGY 48 0.0008
626 ELECTROCARDIOGRAM QT PROLONGED 30 0.0008
627 ANGER 28 0.0008
628 PRESCRIBED OVERDOSE 16 0.0008
629 DYSPNOEA 467 0.0008
630 RESTLESS LEGS SYNDROME 15 0.0008
631 THROAT IRRITATION 37 0.0008
632 STOMATITIS 50 0.0008
633 GASTROOESOPHAGEAL REFLUX DISEASE 66 0.0008
634 DISEASE RECURRENCE 39 0.0008
635 MALAISE 359 0.0008
636 MUSCLE SPASTICITY 10 0.0008
637 THERAPY CHANGE 8 0.0008
638 DYSKINESIA 33 0.0008
639 BRADYCARDIA 43 0.0008
640 DEPRESSION 184 0.0008
641 PHARMACEUTICAL PRODUCT COMPLAINT 21 0.0008
642 WHITE BLOOD CELL COUNT INCREASED 31 0.0008
643 NIGHT SWEATS 26 0.0008
644 INTENTIONAL DOSE OMISSION 23 0.0008
645 NECK PAIN 45 0.0008
646 RED BLOOD CELL COUNT DECREASED 23 0.0008
647 ORAL PAIN 18 0.0008
648 MUSCULAR WEAKNESS 91 0.0008
649 OCULAR HYPERAEMIA 38 0.0008
650 LEUKOPENIA 40 0.0008
651 SALIVARY HYPERSECRETION 8 0.0008
652 ANHEDONIA 21 0.0008
653 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
654 SECRETION DISCHARGE 10 0.0008
655 PLATELET COUNT DECREASED 85 0.0008
656 HEART RATE IRREGULAR 18 0.0008
657 DYSPNOEA EXERTIONAL 30 0.0008
658 ERYTHEMA 163 0.0008
659 CARPAL TUNNEL SYNDROME 11 0.0008
660 SLUGGISHNESS 8 0.0008
661 WHITE BLOOD CELL COUNT DECREASED 85 0.0008
662 ALANINE AMINOTRANSFERASE INCREASED 48 0.0008
663 DEVICE OCCLUSION 11 0.0008
664 PRODUCT PRESCRIBING ISSUE 17 0.0008
665 FATIGUE 607 0.0008
666 SEASONAL ALLERGY 11 0.0008
667 EPISTAXIS 58 0.0008
668 OSTEOMYELITIS 14 0.0008
669 HYPERBILIRUBINAEMIA 8 0.0008
670 ACUTE MYELOID LEUKAEMIA 12 0.0008
671 SYNCOPE 77 0.0008
672 DRUG INTERACTION 122 0.0008
673 HAEMORRHOIDS 15 0.0008
674 HYPERGLYCAEMIA 28 0.0008
675 EXTRA DOSE ADMINISTERED 31 0.0008
676 FOLLICULITIS 8 0.0008
677 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
678 EYE DISORDER 25 0.0008
679 DIZZINESS 378 0.0008
680 SARS-COV-2 TEST POSITIVE 10 0.0008
681 COUGH 212 0.0008
682 EPILEPSY 23 0.0008
683 ACUTE MYOCARDIAL INFARCTION 22 0.0007
684 ECZEMA 39 0.0007
685 CHEST PAIN 138 0.0007
686 DECREASED ACTIVITY 8 0.0007
687 NEPHROLITHIASIS 34 0.0007
688 SCHIZOPHRENIA 9 0.0007
689 BACK PAIN 172 0.0007
690 FEEDING DISORDER 15 0.0007
691 BONE MARROW FAILURE 15 0.0007
692 OEDEMA 40 0.0007
693 HOSPITALISATION 113 0.0007
694 HEPATIC ENZYME INCREASED 50 0.0007
695 HYPERSOMNIA 21 0.0007
696 ACUTE HEPATIC FAILURE 10 0.0007
697 OSTEOARTHRITIS 31 0.0007
698 RESPIRATORY TRACT INFECTION 19 0.0007
699 LOWER LIMB FRACTURE 14 0.0007
700 THIRST 13 0.0007
701 CYST 9 0.0007
702 HYPOACUSIS 31 0.0007
703 PAIN 442 0.0007
704 TOOTHACHE 13 0.0007
705 WOUND 20 0.0007
706 DEVICE RELATED INFECTION 11 0.0007
707 CHROMATURIA 16 0.0007
708 EYE INFECTION 8 0.0007
709 PAIN IN JAW 20 0.0007
710 BLOOD PRESSURE ABNORMAL 14 0.0007
711 SINUSITIS 72 0.0007
712 PRODUCT USE ISSUE 132 0.0007
713 FIBROMYALGIA 17 0.0007
714 VISION BLURRED 96 0.0007
715 SPINAL FRACTURE 14 0.0007
716 PREMATURE BABY 21 0.0007
717 STAPHYLOCOCCAL INFECTION 23 0.0007
718 ARRHYTHMIA 33 0.0007
719 HEAD INJURY 22 0.0007
720 FULL BLOOD COUNT DECREASED 14 0.0007
721 THERAPEUTIC RESPONSE SHORTENED 23 0.0007
722 HOT FLUSH 52 0.0007
723 ABSCESS 11 0.0007
724 BLOOD URINE PRESENT 13 0.0007
725 EUPHORIC MOOD 7 0.0007
726 METASTASES TO LIVER 12 0.0007
727 INITIAL INSOMNIA 7 0.0007
728 MUSCLE TIGHTNESS 11 0.0007
729 CARDIOMYOPATHY 10 0.0007
730 EYE HAEMORRHAGE 9 0.0007
731 QUALITY OF LIFE DECREASED 9 0.0007
732 PULMONARY OEDEMA 30 0.0007
733 RASH PAPULAR 15 0.0007
734 ANXIETY 190 0.0007
735 SINUS CONGESTION 9 0.0007
736 GASTROENTERITIS VIRAL 12 0.0007
737 KIDNEY INFECTION 13 0.0007
738 APHASIA 20 0.0007
739 BLOOD PRESSURE DECREASED 44 0.0007
740 JOINT DISLOCATION 7 0.0007
741 ADRENAL INSUFFICIENCY 8 0.0007
742 GAIT INABILITY 22 0.0007
743 BREAST PAIN 7 0.0007
744 DISCOMFORT 40 0.0007
745 CATARACT 39 0.0007
746 EYE PRURITUS 22 0.0007
747 CONTUSION 63 0.0007
748 CYTOPENIA 8 0.0007
749 DYSSTASIA 19 0.0007
750 CARDIOMEGALY 8 0.0006
751 MUSCULOSKELETAL PAIN 34 0.0006
752 MEDICATION ERROR 36 0.0006
753 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
754 RENAL IMPAIRMENT 54 0.0006
755 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
756 PARANOIA 11 0.0006
757 OROPHARYNGEAL PAIN 59 0.0006
758 BODY TEMPERATURE INCREASED 13 0.0006
759 PERIPHERAL SWELLING 98 0.0006
760 MELAENA 14 0.0006
761 BRONCHITIS 47 0.0006
762 FOOT FRACTURE 12 0.0006
763 CRYING 23 0.0006
764 ILLNESS 65 0.0006
765 RESPIRATORY TRACT CONGESTION 10 0.0006
766 RASH MACULAR 22 0.0006
767 MIGRAINE 60 0.0006
768 RESTLESSNESS 23 0.0006
769 SEROTONIN SYNDROME 12 0.0006
770 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16 0.0006
771 HYPERTHYROIDISM 9 0.0006
772 TREATMENT NONCOMPLIANCE 34 0.0006
773 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
774 COGNITIVE DISORDER 29 0.0006
775 CEREBROVASCULAR ACCIDENT 103 0.0006
776 TOOTH INFECTION 8 0.0006
777 PERICARDIAL EFFUSION 14 0.0006
778 PANIC ATTACK 22 0.0006
779 PRESCRIBED UNDERDOSE 12 0.0006
780 EAR INFECTION 16 0.0006
781 PERICARDITIS 10 0.0006
782 PRODUCT PHYSICAL ISSUE 12 0.0006
783 LYMPHADENOPATHY 21 0.0006
784 LOSS OF CONSCIOUSNESS 76 0.0006
785 FACE OEDEMA 10 0.0006
786 INFLUENZA 66 0.0006
787 HEMIPARESIS 10 0.0006
788 PALPITATIONS 69 0.0006
789 MIDDLE INSOMNIA 11 0.0006
790 PRODUCT DOSE OMISSION ISSUE 173 0.0006
791 DEPRESSED MOOD 31 0.0006
792 AGITATION 43 0.0006
793 MOBILITY DECREASED 42 0.0006
794 HAEMATURIA 20 0.0006
795 NEEDLE ISSUE 17 0.0006
796 OSTEOPOROSIS 24 0.0006
797 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
798 INSOMNIA 155 0.0006
799 FRACTURE 11 0.0006
800 PROSTATIC SPECIFIC ANTIGEN INCREASED 8 0.0006
801 BONE PAIN 34 0.0006
802 CHOLELITHIASIS 19 0.0006
803 HAEMATOMA 15 0.0006
804 MUSCLE SPASMS 106 0.0006
805 BASAL CELL CARCINOMA 9 0.0006
806 WEIGHT INCREASED 129 0.0006
807 PSYCHOTIC DISORDER 17 0.0006
808 BONE DENSITY DECREASED 18 0.0006
809 CYANOSIS 9 0.0006
810 VIRAL INFECTION 19 0.0006
811 RESPIRATORY DISORDER 17 0.0006
812 PNEUMOTHORAX 9 0.0006
813 PAIN IN EXTREMITY 167 0.0006
814 HALLUCINATION, AUDITORY 9 0.0006
815 MALIGNANT NEOPLASM PROGRESSION 58 0.0006
816 SHOCK 13 0.0006
817 EYE SWELLING 21 0.0006
818 HEPATOCELLULAR INJURY 8 0.0006
819 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
820 MATERNAL EXPOSURE DURING PREGNANCY 50 0.0006
821 ILL-DEFINED DISORDER 34 0.0006
822 ANGINA PECTORIS 16 0.0006
823 RENAL DISORDER 26 0.0006
824 THERAPY INTERRUPTED 39 0.0005
825 ADVERSE DRUG REACTION 49 0.0005
826 RASH 237 0.0005
827 ANAPHYLACTIC SHOCK 14 0.0005
828 DRUG-INDUCED LIVER INJURY 17 0.0005
829 ACNE 41 0.0005
830 DISTURBANCE IN ATTENTION 29 0.0005
831 MENTAL IMPAIRMENT 13 0.0005
832 FLUID RETENTION 27 0.0005
833 TOOTH LOSS 11 0.0005
834 MOVEMENT DISORDER 17 0.0005
835 BURNING SENSATION 37 0.0005
836 GASTROINTESTINAL HAEMORRHAGE 44 0.0005
837 DERMATITIS 11 0.0005
838 DISEASE PROGRESSION 62 0.0005
839 INCREASED APPETITE 10 0.0005
840 MUSCULOSKELETAL DISCOMFORT 9 0.0005
841 HIP ARTHROPLASTY 8 0.0005
842 HERPES ZOSTER 30 0.0005
843 AGEUSIA 13 0.0005
844 HYPERHIDROSIS 67 0.0005
845 CHEST DISCOMFORT 53 0.0005
846 RASH PRURITIC 28 0.0005
847 LIMB INJURY 14 0.0005
848 CHRONIC KIDNEY DISEASE 39 0.0005
849 THERAPY PARTIAL RESPONDER 8 0.0005
850 NASOPHARYNGITIS 94 0.0005
851 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
852 HYPOAESTHESIA 76 0.0005
853 SKIN ULCER 13 0.0005
854 CEREBRAL HAEMORRHAGE 18 0.0005
855 RASH ERYTHEMATOUS 24 0.0005
856 DEMENTIA 14 0.0005
857 INFECTION 72 0.0005
858 PRURITUS 188 0.0005
859 METASTASES TO BONE 8 0.0005
860 ARTHRALGIA 202 0.0005
861 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
862 JOINT SWELLING 58 0.0005
863 PULMONARY HYPERTENSION 10 0.0005
864 APATHY 7 0.0005
865 AMNESIA 31 0.0005
866 DEATH 408 0.0005
867 HAEMATEMESIS 12 0.0005
868 MOOD SWINGS 15 0.0005
869 IRRITABLE BOWEL SYNDROME 10 0.0005
870 HYPOAESTHESIA ORAL 7 0.0005
871 PRODUCT DISPENSING ERROR 10 0.0005
872 LOCALISED INFECTION 11 0.0005
873 ROAD TRAFFIC ACCIDENT 19 0.0005
874 STEVENS-JOHNSON SYNDROME 10 0.0004
875 PREGNANCY 9 0.0004
876 HEPATOTOXICITY 10 0.0004
877 INTENTIONAL SELF-INJURY 9 0.0004
878 THERAPY NON-RESPONDER 20 0.0004
879 DRUG ABUSE 37 0.0004
880 MEMORY IMPAIRMENT 61 0.0004
881 MOOD ALTERED 12 0.0004
882 SKIN LESION 12 0.0004
883 CONJUNCTIVITIS 8 0.0004
884 CARDIAC FAILURE 34 0.0004
885 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
886 MYALGIA 72 0.0004
887 NERVOUSNESS 22 0.0004
888 DEAFNESS 11 0.0004
889 VISUAL IMPAIRMENT 52 0.0004
890 SKIN CANCER 9 0.0004
891 PRODUCT SUBSTITUTION ISSUE 24 0.0004
892 RENAL FAILURE 55 0.0004
893 SKIN DISCOLOURATION 19 0.0004
894 DYSTONIA 8 0.0004
895 SKIN FISSURES 8 0.0004
896 FEAR 11 0.0004
897 LABORATORY TEST ABNORMAL 12 0.0004
898 TOOTH DISORDER 9 0.0004
899 SINUS DISORDER 8 0.0004
900 PANCREATITIS 21 0.0004
901 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
902 FOETAL EXPOSURE DURING PREGNANCY 32 0.0004
903 SURGERY 23 0.0004
904 GALLBLADDER DISORDER 7 0.0004
905 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
906 URTICARIA 65 0.0004
907 LIMB DISCOMFORT 12 0.0004
908 FLUSHING 39 0.0004
909 BLOOD GLUCOSE DECREASED 18 0.0004
910 CARDIAC FAILURE CONGESTIVE 30 0.0004
911 CEREBRAL INFARCTION 9 0.0004
912 PALLOR 10 0.0004
913 FEELING ABNORMAL 88 0.0004
914 VISUAL ACUITY REDUCED 12 0.0004
915 SKIN DISORDER 12 0.0004
916 UNEVALUABLE EVENT 27 0.0004
917 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
918 PARAESTHESIA 56 0.0004
919 FEMUR FRACTURE 11 0.0004
920 PRODUCT DOSE OMISSION 23 0.0004
921 MUSCLE TWITCHING 8 0.0003
922 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
923 EMOTIONAL DISTRESS 41 0.0003
924 SUICIDAL IDEATION 31 0.0003
925 DRUG DEPENDENCE 54 0.0003
926 IMPAIRED HEALING 11 0.0003
927 WITHDRAWAL SYNDROME 14 0.0003
928 THROAT TIGHTNESS 9 0.0003
929 KNEE ARTHROPLASTY 7 0.0003
930 HEPATIC FAILURE 10 0.0003
931 DRUG EFFECT INCOMPLETE 12 0.0003
932 LIP SWELLING 11 0.0003
933 DRY SKIN 44 0.0003
934 FEELING HOT 20 0.0003
935 ADVERSE EVENT 30 0.0003
936 BLOOD GLUCOSE INCREASED 61 0.0003
937 GASTRIC DISORDER 11 0.0003
938 PSORIATIC ARTHROPATHY 13 0.0003
939 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
940 ALOPECIA 61 0.0003
941 EXPOSURE VIA SKIN CONTACT 8 0.0003
942 ARTHROPATHY 17 0.0003
943 BLISTER 17 0.0003
944 IRRITABILITY 18 0.0003
945 JAUNDICE 8 0.0003
946 THERAPEUTIC RESPONSE DECREASED 18 0.0003
947 SUICIDE ATTEMPT 18 0.0003
948 HAEMORRHAGE 31 0.0003
949 MULTIPLE SCLEROSIS 14 0.0003
950 INFLAMMATION 15 0.0003
951 NEOPLASM PROGRESSION 10 0.0003
952 LIVER INJURY 7 0.0003
953 TOXICITY TO VARIOUS AGENTS 48 0.0003
954 SKIN EXFOLIATION 23 0.0003
955 INJECTION SITE MASS 10 0.0003
956 FUNGAL INFECTION 9 0.0003
957 INFLUENZA LIKE ILLNESS 22 0.0003
958 CARDIAC DISORDER 25 0.0003
959 DRUG WITHDRAWAL SYNDROME 23 0.0003
960 MYELOSUPPRESSION 9 0.0002
961 INTENTIONAL OVERDOSE 16 0.0002
962 INJURY 17 0.0002
963 LIVER FUNCTION TEST ABNORMAL 7 0.0002
964 TREATMENT FAILURE 19 0.0002
965 EMOTIONAL DISORDER 7 0.0002
966 DEVICE ISSUE 20 0.0002
967 SKIN IRRITATION 10 0.0002
968 VAGINAL HAEMORRHAGE 9 0.0002
969 INTERSTITIAL LUNG DISEASE 10 0.0002
970 RHEUMATOID ARTHRITIS 23 0.0002
971 BLINDNESS 8 0.0002
972 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
973 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
974 EXPOSURE DURING PREGNANCY 12 0.0002
975 PSORIASIS 25 0.0002
976 INJECTION SITE HAEMORRHAGE 14 0.0002
977 PRODUCT QUALITY ISSUE 23 0.0002
978 DEVICE LEAKAGE 7 0.0002
979 DEVICE DISLOCATION 7 0.0002
980 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
981 INJECTION SITE SWELLING 12 0.0002
982 THERAPY CESSATION 8 0.0002
983 MYOCARDIAL INFARCTION 25 0.0001
984 BREAST CANCER 13 0.0001
985 BLADDER CANCER 8 0.0001
986 DERMATITIS ATOPIC 7 0.0001
987 DRUG DOSE OMISSION 21 0.0001
988 CONVULSION 7 0.0001
989 INJECTION SITE PRURITUS 8 0.0001
990 INJECTION SITE PAIN 35 0.0001
991 INJECTION SITE ERYTHEMA 14 0.0001
992 PROSTATE CANCER 8 0.0001